Financhill
Back

Galectin Therapeutics, Inc. 10K Form

Sell
49

GALT
Galectin Therapeutics, Inc.

Last Price:
$6.31
Seasonality Move:
33.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive GALT News And Ratings

See the #1 stock for the next 7 days that we like better than GALT

GALT Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-3.5M
Price / Cash Flow: 0
Annual Sales: $-1.95
Price / Book: 0

Profitability

EPS (TTM): -0.59130
Net Income (TTM): $-37.3M
Gross Margin: $-37K
Return on Equity: 0%
Return on Assets: -220.83%

Galectin Therapeutics, Inc. Earnings Forecast

Key Galectin Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 24 years have been positive in 11 years.

Galectin Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GALT
CUSIP: 363225
Website: galectintherapeutics.com

Debt

Debt-to-Equity Ratio: -0.99
Current Ratio: 0.09
Quick Ratio: 0.08

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GALT Technical Analysis vs Fundamental Analysis

Sell
49
Galectin Therapeutics, Inc. (GALT) is a Sell

Is Galectin Therapeutics, Inc. a Buy or a Sell?